NCT04499625

Brief Summary

Several approaches have been used in order to regenerate bone in the upper jaw in case of insufficient alveolar bone height for implant placement. However, new emerging techniques need to be assessed and compared to conventional methods in order to define their potential indications. The purpose of the present randomized controlled clinical trial was to compare the clinical outcomes of two sinus floor elevation techniques: conventional lateral window technique versus a novel transalveolar approach using hydrodynamic ultrasonic device.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2013

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2013

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2018

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

July 14, 2020

Completed
22 days until next milestone

First Posted

Study publicly available on registry

August 5, 2020

Completed
Last Updated

August 5, 2020

Status Verified

July 1, 2020

Enrollment Period

5 years

First QC Date

July 14, 2020

Last Update Submit

July 31, 2020

Conditions

Outcome Measures

Primary Outcomes (8)

  • Sinus membrane perforation

    Presence/absence of sinus membrane perforation during the surgery

    During the surgery (from beginning to end)

  • Surgical procedure duration

    The time measurement started from the administration of local anesthesia and ended when the placement of final suture was completed. The time was measured using a stopwatch.

    From beginning of surgery until the end of surgery

  • Edema

    Presence/absence of edema postoperatively

    From the end of surgery up to 1 week postoperatively

  • Hematoma

    Presence/absence of hematoma postoperatively

    From the end of surgery up to 1 week postoperatively

  • Postsurgical bleeding

    Presence/absence of bleeding postoperatively

    From the end of surgery up to 1 week postoperatively

  • Nasal discharge

    Presence/absence of nasal discharge postoperatively

    From the end of surgery up to 1 week postoperatively

  • NSAID consumption

    Quantification of NSAID consumption per day up to 1 week postoperatively (tablets/per day)

    From the end of surgery up to 1 week postoperatively

  • Patient related outcome measures (PROMs)

    PROMs were assessed with a questionnaire using a visual analogue scale (VAS), which was given to all participants in order to assess their perception before, during, and after the intervention. A graduated scale from 0 to 10 was used, with a lower score presenting a better outcome.

    From right before the surgery up to 1 week postoperatively

Secondary Outcomes (2)

  • Radiographic outcomes

    From the baseline (surgery procedure) up to 1 year post-surgery

  • Implant survival rates

    From the baseline (surgery procedure) up to 1 year post-surgery

Study Arms (2)

Control - Lateral window

OTHER

Standard surgical technique to access maxillary sinus for sinus floor augmentation procedure.

Procedure: Sinus floor elevation

Test - Hydrodynamic transalveolar approach

EXPERIMENTAL

Novel transalveolar approach (using an ultrasonic device) to access maxillary sinus for sinus floor augmentation procedure.

Device: Sinus floor elevation using an ultrasonic device

Interventions

Control - Lateral window
Test - Hydrodynamic transalveolar approach

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • edentulism in the posterior maxilla (unitary or plural)
  • need of a sinus floor augmentation procedure before implant placement

You may not qualify if:

  • any uncontrolled systemic disease
  • ongoing chemo- or radiotherapy
  • history of maxillary sinus diseases or acute sinus-related issues

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Bacevic M, Compeyron Y, Lecloux G, Rompen E, Lambert F. Intraoperative and postoperative outcomes of sinus floor elevation using the lateral window technique versus the hydrodynamic transalveolar approach: a preliminary randomized controlled trial. Clin Oral Investig. 2021 Sep;25(9):5391-5401. doi: 10.1007/s00784-021-03847-2. Epub 2021 Mar 10.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 14, 2020

First Posted

August 5, 2020

Study Start

May 1, 2013

Primary Completion

May 1, 2018

Study Completion

May 1, 2018

Last Updated

August 5, 2020

Record last verified: 2020-07